-
Entity
-
Individual
-
Location
-
C/O Foamix Pharmaceuticals Ltd., 2 Holtzman St, Weizmann Science Park, Rehovot, Israel
-
Summary
-
The estimated net worth of Matthew T. Wiley is at least $264 K dollars as of June 18, 2024. Matthew T. Wiley is the Chief Commercial Officer of VYNE Therapeutics Inc. and owns shares of VYNE Therapeutics Inc. (VYNE) stock worth about $249 K. Matthew T. Wiley is the Chief Commercial Officer of BioXcel Therapeutics, Inc. and owns shares of BioXcel Therapeutics, Inc. (BTAI) stock worth about $14.8 K.